Independence Bank of Kentucky’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-780
Closed -$143K 632
2025
Q4
$143K Buy
780
+38
+5% +$6.67K 0.02% 318
2025
Q3
$114K Hold
742
0.01% 342
2025
Q2
$104K Hold
742
0.01% 342
2025
Q1
$109K Hold
742
0.02% 335
2024
Q4
$97.2K Sell
742
-61
-8% -$8.54K 0.02% 346
2024
Q3
$125K Buy
803
+45
+6% +$7.26K 0.03% 306
2024
Q2
$118K Buy
758
+500
+194% +$75.2K 0.03% 288
2024
Q1
$34.9K Hold
258
0.01% 351
2023
Q4
$34.7K Hold
258
0.01% 334
2023
Q3
$34.9K Hold
258
0.01% 309
2023
Q2
$36.9K Hold
258
0.01% 306
2023
Q1
$35.7K Hold
258
0.02% 282
2022
Q4
$35K Hold
258
0.02% 279
2022
Q3
$28K Sell
258
-72
-22% -$9.13K 0.01% 280
2022
Q2
$44K Hold
330
0.02% 253
2022
Q1
$44K Hold
330
0.02% 267
2021
Q4
$38K Hold
330
0.02% 265
2021
Q3
$40K Hold
330
0.02% 256
2021
Q2
$40K Buy
330
+82
+33% +$9K 0.02% 254
2021
Q1
$25K Hold
248
0.01% 284
2020
Q4
$25K Hold
248
0.01% 278
2020
Q3
$27K Hold
248
0.02% 255
2020
Q2
$26K Hold
248
0.02% 237
2020
Q1
$22K Hold
248
0.02% 235
2019
Q4
$25K Hold
248
0.02% 248
2019
Q3
$22K Buy
+248
New +$21.5K 0.02% 255

Other funds holding AZN

Independence Bank of Kentucky's AZN Position: Q1 2026 in Review

Independence Bank of Kentucky sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 780 shares — an estimated $143K sold.

Independence Bank of Kentucky first reported a position in AZN in Q3 2019 and held it in 26 quarters. The position peaked at $143K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Independence Bank of Kentucky reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Independence Bank of Kentucky sold 780 AstraZeneca shares in Q1 2026, an estimated $143K.
  • Independence Bank of Kentucky first reported a position in AstraZeneca in Q3 2019 and held it in 26 quarters.
  • Independence Bank of Kentucky's AstraZeneca position peaked at $143K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Independence Bank of Kentucky's 13F filing for Q1 2026, filed 30 Apr 2026.